Daniel J Sprague

8PUBLICATIONS
25CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsEpigenetics (incl. genome methylation and epigenomics)Innate immunityMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 01, 2025
Aleutianamine B, A Novel Chiral Sulfoxide Isolated from Latrunculia spp. and Generated via Semi-Synthesis, Exhibits Selectivity for Ovarian Cancer Cells.

Cody F Dickinson, Samuel M Flipse, Jared S Wood

|Aug 04, 2025
Target-Based Design of Praziquantel Analogs at Cestode TRPMPZQ.

Daniel J Sprague, Sang-Kyu Park, Marc Kaethner

|Apr 25, 2025
BRD9 functions as a methylarginine reader to regulate AKT-EZH2 signaling.

Shasha Yin, Charles Brobbey, Lauren E Ball

|Nov 18, 2024
The TRIM33 Bromodomain Recognizes Histone Lysine Lactylation.

Raymundo Nuñez, Paul F W Sidlowski, Erica A Steen

|May 07, 2024
Target-based discovery of a broad-spectrum flukicide.

Daniel J Sprague, Sang-Kyu Park, Svenja Gramberg

|Apr 15, 2024
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types.

Rachel A Jones Lipinski, Jennifer S Stancill, Raymundo Nuñez

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan S Marchant

2 joint publications

Claudia M Rohr

2 joint publications

David Maillard

2 joint publications

Thomas Spangenberg